Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: Cryst Growth Des. 2009;9(1):432–441. doi: 10.1021/cg8006712

Supramolecular synthesis based on a combination of hydrogen- and halogen bonds

Christer B Aakeröy †,*, Nate Schultheiss , Arbin Rajbanshi , John Desper , Curtis Moore
PMCID: PMC2724020  NIHMSID: NIHMS80714  PMID: 20046941

Abstract

A family of supramolecular reagents containing two different binding sites, pyridine and amino-pyrimidine, were allowed to react with iodo- or bromo-substituted benzoic acids in order to assemble individual molecules into larger architectures with precise intermolecular interactions, using a combination of hydrogen- and halogen-bonds. The hydrogen-bond based amino-pyrimidine/carboxylic acid or amino-pyrimidinium/carboxylate synthons are responsible for the assembly of the primary structural motif in every case (7/7 times, 100% supramolecular yield), while I⋯N, Br⋯N, and I⋯O, halogen bonds play a structural supporting role by organizing these supermolecules into extended 1-D and 2-D architectures (5/7 times, 71% supramolecular yield). These results illustrate how two different non-covalent interactions can be employed side-by-side in the reliable construction of extended molecular solid-state networks with predictable connectivity and dimensionality.

Introduction

Successful non-covalent assembly of individual entities into complex heteromeric structures with predetermined connectivities and stoichiometries, which normally relies on a tool-box containing intermolecular interactions such as hydrogen bonds,1 halogen bonds,2 and π-π interactions,3 remains a central challenge within crystal engineering.4 Due to the relatively weak and reversible nature of non-covalent intermolecular interactions, the desired product must typically be obtained and isolated in a single-pot reaction, which makes supramolecular synthesis of complex heteromeric targets particularly difficult.5

Heteromeric synthons such as carboxylic acidpyridine,6 oxime⋯N-heterocycles,7 and carboxylic acidamide,8 represent useful and versatile supramolecular synthetic tools, Scheme 1. However, although the balance between the two interactions has been explored in homomeric molecular solids9, the deliberate combination of different intermolecular interactions such as hydrogen bonds (e.g. amino-pyrimidinecarboxylic acid10) and halogen bonds2 has not received as much attention in the assembly of heteromeric molecular solids (co-crystals).11

Scheme 1.

Scheme 1

A few examples of heteromeric hydrogen-bond and halogen-bond based synthons.

The synthesis of a specific supermolecular target, such as a heteromeric dimer, can be achieved quite readily if the two different building blocks only contain one binding site each, and if there is only one way in which those two moieties can form a heteromeric synthon. However, synthetic predictability and reliability deteriorates quickly when the number of potentially interacting moieties on each reactant is increased. Several computational approaches have been developed in order to characterize and quantify the energetic ‘worth’ of multiple intermolecular interactions within a supramolecular system, however it is not necessarily easy to use such information as the basis for practical and transferable a priori synthetic strategies for co-crystal synthesis and other supramolecular assembly processes.12

A number of systematic structural studies have been performed where hydrogen bonds of different strengths guide and direct the overall assembly of binary and ternary co-crystals in predictable and high-yielding reactions.13 However, a strategy for precise synthesis of more complex co-crystals (e.g., quaternary and quinternary) that only relies on hydrogen bonds may soon run into problems because of unavoidable competition between the intended hydrogen-bond donors/acceptors. Therefore, it may be advantageous and, in the long term, more effective to develop supramolecular strategies that can accommodate two different non-covalent interactions in a complementary manner, or in such a way that they are less likely to interfere with each other. A suitable interaction in this context is the halogen bond, which is typically formed between iodine- or bromine atoms (the halogen-bond donor) and an appropriate halogen-bond acceptor (electron-pair donor) such as an N-heterocycle. Furthermore, the halogen-bond donor can be boosted substantially by fluorination of the backbone to which the halogen-bond donor is attached, as a result of a dramatic increase in the electron-acceptor ability of the iodine or bromine atom.14 Since halogen bonds and hydrogen bonds display considerable strength2a and, importantly, directionality, they offer a good starting point for supramolecular strategies that simultaneously encompass two different non-covalent interactions.

In order to utilize the structure-directing abilities of hydrogen bonds and halogens bonds side-by-side we need bifunctional supramolecular reagents (SR’s) that contain a robust chemical functionality capable of forming hydrogen bonds even in the presence of other potential disruptive moieties, coupled with a functional group that can facilitate the formation of halogen bonds in a reliable manner. The CSD15 provides invaluable assistance for identifying suitable compounds that can take advantage of both interactions by minimizing any potential interference between different synthons.

There are ten known crystal structures of co-crystals/salts resulting from the combination of a carboxylic acid and a SR comprising both an amino-pyrimidine and a pyridine moiety. The carboxylic acid preferentially binds to the former site 9/10 times10a,16 (equivalent to a 90% supramolecular yield), irrespective of reaction conditions and nature of the carboxylic acid, Scheme 2.

Scheme 2.

Scheme 2

The three potential hydrogen-bonding sites on a pyridine/amino-pyrimidine (py/pym) SR (left). In 9/10 cases, the acid binds to an amino-pyrimidine site in preference to the pyridine moiety.

These results clearly demonstrate the robustness of the amino-pyrimidine/carboxylic acid synthon, even in a competitive situation, and we therefore postulated that a pyridine/2-aminopyrimidine-based SR would provide an ideal structure-directing scaffold for constructing supermolecules using assembly-strategies that simultaneously employ hydrogen bonds and halogen bonds. Consequently, by adding a halogen-bond donor (Br or I) to an aromatic carboxylic acid and by allowing it to react with a py/2-aminopym SR, we surmised that py⋯iodine or py⋯bromine halogen bonds would organize the initial hydrogen-bonded assembly formed via carboxylic acid and amino-pyrimidine moieties into extended architectures, Scheme 3.

Scheme 3.

Scheme 3

Supramolecular target constructed from hydrogen bonds and halogen bonds (X = I or Br).

In order to test our design strategy we synthesized three py/2-aminopym SR’s, 1–3, and allowed them to react with either 4-iodobenzoic acid a, 2,3,5,6-tetrafluoro-4-iodo-benzoic acid b, or 2,3,5,6-tetrafluoro-4-bromo-benzoic acid c in a 1:1 ratio, Scheme 4.

Scheme 4.

Scheme 4

Three bifunctional SR’s, 1–3, each possessing two distinctly different hydrogen-bonding moieties, py and amino-pym, and three halogenated aromatic carboxylic acids, a–c.

We obtained seven crystal structures (from a total of nine reactions), which allowed us to probe whether or not combinations of hydrogen bonds and halogen bonds can be employed in a hierarchical fashion to construct predictable supramolecular assemblies.

Experimental

All chemicals were purchased from Aldrich and used without further purification unless noted. The synthesis and characterization of 3-(2-amino-4-methylpyrimidin-6-yl)pyridine 1, 4-(2-amino-4-methylpyrimidin-6-yl)pyridine 2, and 1-(2-amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne 3 are reported elsewhere.17,18 2,3,5,6-Tetrafluoro-4-iodobenzaldehyde and 2,3,5,6-tetrafluoro-4-bromo-benzaldehyde were synthesized following previously published methods.19 Melting points were determined on a Fisher-Johns melting point apparatus and are uncorrected. Compounds were prepared for infrared spectroscopic (IR) analysis as a mixture in KBr. 1H NMR spectra were recorded on a Varian Unity plus 200 MHz spectrometer in CDCl3. Electrospray Ionization – Ion-Trap Mass Spectrometry (ESI-IT-MS) was carried out on a Bruker Daltonics Esquire 3000 Plus.

Synthesis

2,3,5,6-Tetrafluoro-4-iodobenzoic acid, b

A solution of 2,3,5,6-tetrafluoro-4-iodobenzaldehyde (1.52g, 5.20 mmol) in acetone (50 mL) was brought to reflux, when a saturated aqueous solution of KMnO4 (1.67g, 10.57 mmol) was added. The reaction was heated under reflux for 18h. Upon completion the reaction mixture was filtered hot and the precipitate washed with acetone. The filtrate and the acetone wash were combined and concentrated using a rotary evaporator. The residue was treated with dilute HCl (5 %) and extracted into dichloromethane. The organic layer was washed with water, dried over magnesium sulfate and allowed to evaporate yielding a white solid, 1.29g, 81%. Dec. 140 °C; 1H NMR (δH; 200 MHz, CDCl3): 8.173 (br s); IR (KBr pellet): υ 2996, 1700, 1475, 979, 718 cm−1; ESI-IT-MS m/z 318 ([b - H]).

2,3,5,6-Tetrafluoro-4-bromobenzoic acid, c

A solution of 2,3,5,6-tetrafluoro-4-bromobenzaldehyde (1.54g, 6.29 mmol) in acetone (60 mL) was brought to reflux, when a saturated aqueous solution of KMnO4 (2.01g, 12.72 mmol) was added. The reaction was kept under reflux for 18h. Upon completion the reaction mixture was filtered hot and the precipitate washed with acetone. The filtrate and the acetone wash were combined and concentrated by rotary evaporator. The residue was treated with dilute HCl (5 %) and extracted into dichloromethane. The organic layer was washed with water, dried over magnesium sulfate and evaporated by rotary evaporator yielding a white solid, 1.32g, 81%. M.p. 128 – 130 °C; 1H NMR (δH; 200 MHz, CDCl3): 10.16 (br s); IR (KBr pellet): υ 2996, 1711, 1475, 979, 712 cm−1; ESI-IT-MS m/z 270 ([c - H])

Supramolecular synthesis

3-(2-Amino-4-methylpyrimidin-6-yl)pyridine:4-iodobenzoic acid, 1a

3-(2-Amino-4-methylpyrimidin-6-yl)pyridine (10mg, 0.05 mmol) and 4-iodobenzoic acid (13mg, 0.05 mmol) were placed in a beaker containing an ethyl acetate/toluene (2:1) mixture and heated until a clear homogeneous solution was obtained. After two days of slow evaporation, colorless rod-shaped crystals were obtained. M.p. 152–154 °C; IR (KBr pellet) υ 3329 and 3083 cm−1 (NH2, m), 2413 and 1921 cm−1 (O-H⋯N, br), 1685 cm−1 (C=O, m).

3-(2-Amino-4-methylpyrimidin-6-yl)pyridine:2,3,5,6-tetrafluoro-4-iodobenzoic acid, 1b

3-(2-Amino-4-methylpyrimidin-6-yl)pyridine (10mg, 0.05 mmol) and 2,3,5,6-tetrafluoro-4-iodobenzoic acid (17mg, 0.05 mmol) were placed in a beaker containing ethanol (6 mL) and heated until a clear homogeneous solution was obtained. After two days of slow evaporation, colorless rod-shaped crystals were obtained. M.p. 196–198 °C; IR (KBr pellet) υ 3334 and 3104 cm−1 (NH2, m), 2407 and 1972 cm−1 (O-H⋯N, br), 1680 cm−1 (C=O, m), 963 cm−1 (C-I).

4-(2-Amino-4-methylpyrimidin-6-yl)pyridine:4-iodobenzoic acid, 2a

4-(2-Amino-4-methylpyrimidin-6-yl)pyridine (10mg, 0.05 mmol) and 4-iodobenzoic acid (13mg, 0.05 mmol) were placed in a vial containing acetonitrile (6 mL) and heated until a clear homogeneous solution was obtained. After two days of slow evaporation, orange block-shaped crystals were obtained. M.p. 181–183 °C; IR (KBr pellet) υ 3334 and 3176 cm−1 (NH2, m), 2428 and 1895 cm−1 (O-H⋯N, br), 1660 cm−1 (C=O, m).

4-(2-Amino-4-methylpyrimidin-6-yl)pyridine:2,3,5,6-tetrafluoro-4-iodobenzoic acid, 2b

3-(2-Amino-4-methylpyrimidin-6-yl)pyridine (10mg, 0.05 mmol) and 2,3,5,6-tetrafluoro-4-iodobenzoic acid (17mg, 0.05 mmol) were placed in a vial containing ethanol/ethyl acetate (3:2) and heated until a clear homogeneous solution was obtained. After one day of slow evaporation, colorless rod-shaped crystals were obtained. Dec. 210 °C; IR (KBr pellet) υ 3350 and 2996 cm−1 (NH2, m), 2387 and 1967 cm−1 (O-H⋯N, br), 1690 cm−1 (C=O, m), 968 cm−1 (C-I).

4-(2-Amino-4-methylpyrimidin-6-yl)pyridine:2,3,5,6-tetrafluoro-4-bromobenzoic acid, 2c

3-(2-Amino-4-methylpyrimidin-6-yl)pyridine (10mg, 0.05 mmol) and 2,3,5,6-tetrafluoro-4-bromobenzoic acid (17mg, 0.06 mmol) were placed in a vial containing nitromethane/acetonitrile (5:1) and heated until a clear homogeneous solution was obtained. After one day of slow evaporation, colorless rod-shaped crystals were obtained. M.p. 204–206 °C; IR (KBr pellet) υ 3340 and 3044 cm−1 (NH2, m), 2361 and 1962 cm−1 (O-H⋯N, br), 1696 cm−1 (C=O, m).

1-(2-Amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne:4-iodobenzoic acid, 3a

1-(2-Amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne (10mg, 0.04 mmol) and 4-iodobenzoic acid (12mg, 0.04 mmol) were placed in a vial containing a methanol/nitromethane solution (2:1) and heated until a clear homogeneous solution was obtained. After four days of slow evaporation, colorless rod-shaped crystals were obtained. M.p. 198–200 °C; IR (KBr pellet) υ 3300 and 3186 cm−1 (NH2, m), 2478 and 1890 cm−1 (O-H⋯N, br), 1685 cm−1 (C=O, m), 2216 (C≡C, m)

1-(2-Amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne:2,3,5,6-tetrafluoro-4-bromobenzoic acid, 3c

1-(2-Amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne (10mg, 0.04 mmol) and 2,3,5,6-tetrafluoro-4-bromobenzoic acid (12mg, 0.04 mmol) were placed in a vial containing ethanol (6 mL) and heated until a clear homogeneous solution was obtained. After four days of evaporation, colorless rod-shaped crystals were obtained. M.p. 178–180 °C; IR (KBr pellet) υ 3257 and 3186 cm−1 (NH2, m), 2358 and 1976 cm−1 (O-H⋯N, br), 1702 cm−1 (C=O, m), 2221 (C≡C, m).

X-ray Crystallography

Datasets were collected on a SMART APEX or a SMART 1000 using MoKα radiation and, where noted, were corrected for absorption using the multi-scan procedure implemented by SADABS. Data were collected using SMART.20 Initial cell constants were found by small widely separated “matrix” runs. An entire hemisphere of reciprocal space was collected. Scan speed and scan width were chosen based on scattering power and peak rocking curves. Unit cell constants and orientation matrix were improved by least-squares refinement of reflections thresholded from the entire dataset. Integration was performed with SAINT,21 using this improved unit cell as a starting point. Unit cell constants were calculated in SAINT from the final merged dataset. Lorenz and polarization corrections were applied, and data were corrected for absorption. Data were reduced with SHELXTL.22 The structures were solved by direct methods. Unless otherwise noted, hydrogen atoms were assigned to idealized positions and were allowed to ride. All non-hydrogen atoms were given anisotropic thermal parameters.

1a Data were collected on a SMART APEX at −120 °C. Coordinates of the amine hydrogens H12A and H12B and carboxylic acid hydrogen H31 were allowed to refine. 1b Data were collected on a SMART 1000 at −100 °C. 2a Data were collected on a SMART APEX at −120 °C. 2b Data were collected on a SMART APEX at −120 °C. Proton transfer from acid to amine was clearly observed, and the coordinates of the ammonium hydrogen H11 and amine hydrogens H12A and H12B were allowed to refine. 2c Data were collected on a SMART APEX at −120 °C. Proton transfer from acid to amine was clearly observed, and the coordinates of the ammonium hydrogen H11 were allowed to refine. 3a Data were collected on a SMART APEX at −120 °C. Coordinates of the carboxylic acid hydrogen H31 were allowed to refine. 3c Data were collected on a SMART APEX at −120 °C. Proton transfer from acid to amine was clearly observed, and the coordinates of the ammonium hydrogen H11 and amine hydrogens H12A and H12B were allowed to refine.

Results

SR's 1–3 was synthesized through conventional palladium-catalyzed cross-coupling conditions, while halogenated benzoic acids b and c were generated in good yields (~81 %) from the corresponding halogenated benzaldehydes by conventional oxidation with potassium permanganate. SR’s 1–3 were allowed to react with halogenated benzoic acids a–c in a 1:1 ratio resulting in seven 1:1 crystalline materials suitable for analysis by single-crystal X-ray diffraction.

The primary motif in the crystal structure of 1a is an SR:acid dimer assembled via a complementary hydrogen-bond interaction between the carboxylic acid and the amino-pyrimidine moiety (there is also one molecule of toluene in the lattice). The primary hydrogen bonds are O–H⋯N and N–H⋯O interactions with O31⋯N11 and N12⋯O32 distances of 2.5607(19) Å and 3.035(2) Å, respectively. Secondary N–H⋯N hydrogen bonds, N12⋯N21, 2.951(2) Å, between the anti-amino proton and the pyridyl nitrogen atom lead to a four-component supermolecule, Figure 2. No structure-directing I⋯N or I⋯I interactions were observed.

Figure 2.

Figure 2

Four-component supermolecule in 1a comprised of N-H⋯O, O-H⋯N, and N-H⋯N hydrogen bonds. The toluene solvent molecule has been omitted for clarity.

In the crystal structure of 1b the main motif consists of py-pym 1 and 2,3,5,6-tetrafluoro-4-iodobenzoic acid b in a 1:1 ratio; the two molecules are connected through the carboxylic acid and amino-pyrimidine moieties via O–H⋯N and N–H⋯O hydrogen bonds with O31⋯N11 and N12⋯O32 distances of 2.589(7) Å and 2.924(8) Å, respectively. A halogen bond between the iodine atom and the pyridyl nitrogen atom connects the dimers into 1-D chains, r(I⋯N(py)) 2.941 Å, ∠ (C-I-N) 170.7 °, Figure 3.

Figure 3.

Figure 3

1-D chain in 1b, generated through amino-pyrimidine⋯acid and I⋯N synthons.

The 1-D chains are connected into a 2-D wave-like pattern through additional N-H⋯O interactions, N12⋯O32, 2.855(8) Ă, involving the anti-amino proton and the carbonyl oxygen atom of the benzoic acid, Figure 4.

Figure 4.

Figure 4

Extended motif of 1b, displaying a sheet constructed from O–H⋯N, N–H⋯O hydrogen bonds and I⋯N halogen bonds.

The crystal structure of 2a contains dimeric units of SR 2 and 4-iodobenzoic acid, assembled by the carboxylic acid/amino-pyrimidine synthon with O31⋯N11 and N12⋯O32 distances of 2.675(3) Å and 2.818(4) Å, respectively. An I⋯N(py) halogen bond links dimers into 1-D chains, r(I⋯N) 3.004 Å, ∠(C-I-N) 178 °, and adjacent anti-parallel chains are arranged into ribbons through pairs of symmetry related N–H⋯N hydrogen bonds, r(N12⋯N13) 2.250 Å, Figure 5.

Figure 5.

Figure 5

Ladders in the structure of 2a constructed from a combination of O–H⋯N, N–H⋯O, and N–H⋯N hydrogen bonds and I⋯N halogen bonds.

The primary motif in the crystal structure of 2b comprises an ion pair of protonated SR 2 and 2,3,5,6-tetrafluoro-4-iodobenzoate ions, interlinked through charge-assisted hydrogen bonds between the carboxylate and amino-pyrimidinium moieties. The primary hydrogen bonds are N–H+⋯O and N–H⋯O interactions with N11⋯O31 and N12⋯O32 distances of 2.646(5) and 2.801(5) Å, respectively. An I⋯N(py) halogen bond connect dimers into 1-D chains, r(I⋯N) 2.812 Å, ∠(C-I-N) 177 °). The linear chains are linked into a ladder-motif through secondary N–H⋯ O hydrogen bonds (N12⋯O32, 2.808(5) Å), from the anti-ammo proton and the carboxylate oxygen atom, Figure 6.

Figure 6.

Figure 6

1-D strands in 2b formed through a series of hydrogen bonds and halogen bonds.

In the crystal structure of 2c, one protonated SR 2 and one 2,3,5,6-tetrafluoro-4-bromobenzoate ion, form produce a charge-assisted hydrogen-bonds between the carboxylate and the amino-pyrimidinium moieties, Figure 7, with N–H+⋯O and N–H⋯O distances of (N11⋯O32, 2.6430(19) Å) and (N12⋯O32, 2.823(2) Å), respectively. A halogen bond between ion-pairs produces an infinite 1-D chain, r(Br⋯N(py)) 2.840 Å, ∠(C-Br-N 177 °), while the anti-proton of the amino group forms a charge-assisted N–H⋯O hydrogen bond (N12⋯O32, 2.812(2) Å) with a neighboring carboxylate oxygen atom.

Figure 7.

Figure 7

1-D strands in 2c formed through a series of hydrogen bonds and halogen bonds.

The primary motif in the crystal structure of 3a is constructed through O–H⋯N and N–H⋯O interactions with O31⋯N11 and N12⋯O32 distances of 2.643(8) Å and 2.987(8) Å, respectively. An O(methoxy)⋯I halogen bond r(O⋯I) 3.265 Å, ∠(C-I-O) 178 °) produces an infinite chain, while the anti-proton of the amino group forms an N–H⋯N hydrogen bond (N12⋯N13, 3.108(8) Å) with a pyrimidine nitrogen atom of a neighboring strand generating a ladder motif, Figure 8.

Figure 8.

Figure 8

Ladder-type motif in the crystal structure of 3a generated through combinations of hydrogen bonds and O⋯I halogen bonds.

The crystal structure of 3c contains an ion-pair comprising one protonated SR 3 and one 2,3,5,6-tetrafluoro-4-bromobenzoate ion, held together via charge assisted hydrogen bonds, Figure 9. Proton transfer occurs from the carboxylic acid to the pyrimidine nitrogen atom, with N11⋯O31 and N12⋯O32 distances of 2.605(2) Å and 2.832(2) Å, respectively. Adjacent ion-pairs are connected through self-complementary N–H⋯N hydrogen bonds, (N12⋯N13) 3.073(2) Å, producing a four-component aggregate, Figure 9. No short Br⋯N or Br⋯Br interactions are present.

Figure 9.

Figure 9

Supramolecular tetramer in 3b formed via N-H⋯O and N-H⋯N hydrogen bonds.

Discussion

It is possible that a wide variety of intermolecular interactions and supramolecular products could result from the reaction between a pyridine/aminopyrimidine-based SR and a carboxylic acid/halogen-bond donor based-molecule, especially since many of the plausible hetero-and/or homomeric synthons are already well-known in crystal engineering, Scheme 5.

Scheme 5.

Scheme 5

Potential heteromeric and/or homomeric synthons that could form between SR’s 1–3 and halogenated benzoic acids a–c. The R group constitutes an aromatic ring.

However, despite this potential structural ‘chaos’, the overall result is remarkably consistent because in each of the seven cases, the carboxylic binds to the aminopyrimidine site instead of to the pyridyl moiety (even though the latter is a very capable hydrogen-bond acceptor). Although proton transfer does take place in three of the seven structures, 2b, 2c, and 3c, the charge-assisted N–H+⋯O and N–H⋯O synthon is a mimic of the neutral analogue, and does not interfere with the intended assembly. Furthermore, the presence of a carboxylate moiety does not introduce any additional components in these cases.23 I⋯N, Br⋯N, or I⋯O halogen bonds were observed in five of the seven structures (71% supramolecular yield), 1b, 2a–2c, and 3a resulting in extended 1-D or 2-D networks, Table 3.

Table 3.

Halogen bonds in crystal structures 1a–1b, 2a–2c, 3a, and 3c.

SR Acida Structure # Halogen bonds Type of Halogen bond Halogen bond Distance (Å) C-X⋯N (°)
1 I-BA 1a No ---- ---- ----
1 I-F4BA 1b Yes I⋯N 2.941 170.7
2 I-BA 2a Yes I⋯N 3.004 177.1
2 I-F4BA 2b Yes I⋯N 2.812 178.1
2 Br-F4BA 2c Yes Br⋯N 2.840 177.6
3 I-BA 3a Yes I⋯O 3.265 178.1
3 Br-F4BA 3c No ---- ---- ----
a

I-BA = 4-iodobenzoic acid, I-F4BA = 2,3,5,6-tetrafluoro-4-iodobenzoic acid, and Br-F4BA = 2,3,5,6-tetrafluoro-4-bromobenzoic acid.

In each case 1b and 2a–2c halogen bonding occurs with X⋯N (X = I, Br) distances ranging from 2.812 – 3.004 Å, which are considerably shorter than the sum of the van der Waals radii for nitrogen (1.55 Å) and iodine (1.98 Å) or bromine (1.85 Å).24 The I⋯O distance (3.265 Å) found in structure 3a is also within the overall sum of the van der Waals radii for oxygen and iodine (3.53 Å). Furthermore, C-X⋯N angles near linear 170.7–178.1 Å indicate significant (n-σ*) charge-transfer character.2a, 25

It has been determined experimentally and computationally that halogen bond strength decreases in the order I > Br > Cl with various Lewis bases.26 However, due to the limited number of structures within our study, it is difficult to draw precise conclusions about the relative ability of iodine or bromine atoms to act as halogen-bond donors when interacting with a N-containing heterocycle. Thus, to compare the supramolecular reactivity of bromine or iodine and a N-heterocycle, we complemented our results with relevant structural data from the CSD, Table 4.27

Table 4.

Reported crystal structures containing short Br⋯N and I⋯N halogen bonds.

Hits N⋯X distance (mean) N⋯X-C angle (mean)
Br⋯N 29 3.28 Å 163 °
Br⋯N (fluorinated) 11 2.95 Å 173 °
I⋯N 21 3.17 Å 171 °
I⋯N (fluorinated) 41 2.90 Å 173 °

Forty structures were found containing short Br⋯N interactions, and eleven of those involved fluorinated (“activated”) organic bromine. In comparison, sixty-two structures were found containing short I⋯N contacts; both fluorinated (41/62) and non-fluorinated (21/62) organic iodine can drive the supramolecular assembly. This analysis offers further indication that the iodine atom is a superior halogen-bond donor compared to a bromine atom when a nitrogen-containing heterocycle is employed as the halogen-bond acceptor.28

We attempted to determine if an increase in Lewis acidity, due to fluorination around the halogen nuclei (-I or –Br) proves advantageous in forming stronger (based on X⋯N distances) halogen bonds. The molecules in structure 2b display a shorter I⋯N distance, 2.812 Å, in comparison to 2c, which has an Br⋯N distance of 2.840 Å, even though an iodine atom (1.32 Å) is larger than a bromine atom (1.14 Å). As expected, comparing structures 2a and 2c, the halogen bond distance becomes shorter upon fluorination of the aryl ring (3.004 Å vs. 2.812 Å). Furthermore, fluorinated iodo-benzoic acid produces both hydrogen and halogen bonds when combined with 1, whereas the reaction between 4-iodo benzoic acid and 1 did not yield any halogen bonds. These results are consistent with the fact that organic iodine is a stronger Lewis acid than the corresponding bromine species. Furthermore, fluorination of the carbon backbone of the halogen atom increases the structural influence of this halogen-bond donor as a result of an increase in Lewis acidity.

Herein we have described a strategy for designing and constructing supermolecules through combinations of hydrogen bonds and halogen bonds. In all seven structures the carboxylic acidamino-pyrimidine or carboxylateamino-pyrimidinium synthon was present and served to ‘lock’ the two discrete molecules (or ions) into a well-defined dimer. The fact that this synthon was present in each case, means that it can be designated as the primary (and structure directing) intermolecular interaction in this series of compounds. In five of the seven crystal structures, the primary dimers were subsequently organized into infinite 1-D chains through I⋯N or Br⋯N halogen bonds (4/5), and I⋯O halogen bonds (1/2). Intermolecular distances in these seven structures consistently support the expected behavior based upon changes in Lewis acidity of fluorinated/non-fluorinated organic iodine/bromine halogen-bond donor sites.

The relative supramolecular yields of the hydrogen-bond and halogen-bond based synthons, translate into a hierarchy of structural influence that can form the basis for new strategies for the directed assembly of more complex, multimeric, molecular architectures.

Figure 1.

Figure 1

Labeled thermal-ellipsoid plots (50% probability level) of 1a–1b, 2a–2c, 3a, and 3c.

Table 1.

Crystallographic data for 1a–1b, 2a–2c, 3a, and 3c.

1a 1b 2a 2b 2c 3a 3c
Empirical formula C41H38I2N8O4 C17H11F4IN4O2 C17H15IN4O2 C17H11F4IN4O2 C17H11F4BrN4O2 C20H17IN4O3 C20H13BrF4N4O3
MW 960.59 506.20 434.23 506.20 459.21 488.28 513.25
Color, Habit colorless block pink plate colorless, block colorless, needle colorless, prism colorless, needle colorless, plate
Crystal system Triclinic Monoclinic Triclinic Monoclinic Monoclinic Triclinic Triclinic
Space group, Z P-1, 1 P2(1)/n, 4 P-1, 2 P2(1)/c, 4 P2(1)/c, 4 P-1, 2 P-1, 2
a, Å 6.5689(2) 6.6313(15) 7.9304(7) 3.9153(4) 3.78950(10) 6.7820(5) 6.8878(2)
b, Å 9.5508(4) 34.494(8) 10.0937(9) 24.016(2) 24.2190(7) 8.9813(7) 7.4613(2)
c, Å 16.4413(6) 7.6535(18) 11.1149(10) 18.1909(15) 18.1436(5) 16.6932(11) 19.6275(7)
α, ° 102.542(2) 90.00 109.850(3) 90 90 103.905(4) 80.331(2)
β, ° 99.117(2) 103.151(16) 96.640(4) 92.995(4) 93.6890(10) 95.254(4) 88.064(2)
γ, ° 96.534(2) 90.00 96.096(4) 90 90 100.313(5) 77.591(2)
Volume, Å3 982.34(6) 1704.8(7) 821.10(13) 1708.1(2) 1665.68(8) 961.37(12) 971.13(5)
Density, g/cm3 1.624 1.972 1.756 1.968 1.831 1.687 1.755
Temperature, K 293(2) 173(2) 153(2) 153(2) 293(2) 293(2) 293(2)
X-ray wavelength 0.71073 0.71073 0.71073 0.71073 0.71073 0.71073 0.71073
µ mm−1 1.653 1.943 1.968 1.939 1.939 1.695 2.187
θ min, ° 3.18 1.18 1.97 2.78 3.36 2.39 2.11
θ max, ° 27.50 28.76 27.48 27.13 27.12 27.62 27.10
Reflections
  collected 38388 12690 25406 40104 42293 39877 24991
  independent 4495 4007 3768 3737 3662 4426 4292
  observed 4183 2586 3473 2924 3227 3039 3946
Threshold expression >2σ(I) >2σ(I) >2σ(I) >2σ(I) >2σ(I) >2σ(I) >2σ(I)
R1 (observed) 0.0217 0.0664 0.0360 0.0433 0.0243 0.0745 0.0246
wR2 (all) 0.0536 0.1768 0.0966 0.1189 0.0655 0.1928 0.0968

Table 2.

Hydrogen-bond geometries for 1a–1b, 2a–2c, 3a, and 3c.

Structure D-H⋯A d(D-H)/Å d(H⋯A)/Å d(D⋯A)/Å <(DHA)/°
1aa O(31)-H(31)⋯N(11) 0.98(2) 1.59(3) 2.5607(19) 168(2)
N(12)-H(12A)⋯O(32) 0.84(2) 2.21(2) 3.035(2) 168(2)
N(12)-H(12B)⋯N(21)#1 0.83(2) 2.12(2) 2.951(2) 177(2)
1bb O(31)-H(31)··N(11) 0.84 1.77 2.589(7) 165.0
N(12)-H(12A)··O(32) 0.88 2.06 2.924(8) 168.6
N(12)-H(12B)⋯O(32)#1 0.88 2.05 2.855(8) 150.9
2a N(11)-H(12A)⋯O(32) 0.88 1.95 2.818(4) 167.9
O(31)-H(31)⋯N(11) 0.84 1.84 2.675(3) 172.6
2bc N(11)-H(11)⋯O(31) 0.85(6) 1.81(6) 2.646(5) 167(5)
N(12)-H(12A)⋯O(32) 0.88 1.94 2.801(5) 164.7
N(12)-H(12B)⋯O(32)#1 0.88 2.07 2.808(5) 141.4
2cd N(11)-H(11)⋯O(31) 0.82(2) 1.83(2) 2.6430(19) 173(2)
N(12)-H(12A)⋯O(32) 0.84(2) 1.99(2) 2.823(2) 172(2)
N(12)-H(12B)⋯O(32)#1 0.89(2) 2.07(2) 2.812(2) 140(2)
3ae O(31)-H(31)⋯N(11) 0.97(9) 1.71(9) 2.643(8) 162(7)
N(12)-H(12A)⋯O(32) 0.86 2.14 2.987(8) 169.3
N(12)-H(12B)⋯N(13)#1 0.86 2.28 3.108(8) 160.3
3cf N(11)-H(11)⋯O(31) 0.94(3) 1.68(3) 2.605(2) 169(2)
N(12)-H(12A)⋯O(32) 0.93(3) 1.90(3) 2.832(2) 173(2)
N(12)-H(12B)⋯N(13)#1 0.74(3) 2.34(3) 3.073(2) 170(3)
a

#1 −x,−y+2,−z+1

b

#1 −x+2,−y+1,−z+2

c

#1 −x+1,−y+1,−z+1

d

#1 −x+1,−y+2,−z+2

e

#1 −x,−y+1,−z

f

#1 −x+1,−y,−z+1

Acknowledgments

We are grateful for the financial support from ACS-PRF (46011-AC1), the Terry C. Johnson Center for Basic Cancer Research, and for a Grant (P20 RR015563) from the National Center for Research Resources, a component of the National Institutes of Health, and the State of Kansas. This manuscript is solely the responsibility of the authors and does not necessarily represent the official view of the NCRR or NIH.

References

  • 1.(a) Aakeröy CB, Salmon DJ. CrystEngComm. 2005;7:439. doi: 10.1039/b811322j. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) MacGillivray L. CrystEngComm. 2004;6:77. [Google Scholar]; (c) Lehn J-M. Science. 2002;295:2400. doi: 10.1126/science.1071063. [DOI] [PubMed] [Google Scholar]; (d) Desiraju GR. Acc. Chem. Res. 2002;35:565. doi: 10.1021/ar010054t. [DOI] [PubMed] [Google Scholar]; (e) Moulton B, Zaworotko MJ. Chem. Rev. 2001;101:1629. doi: 10.1021/cr9900432. [DOI] [PubMed] [Google Scholar]; (f) Desiraju GR. Angew. Chem., Int. Ed. Engl. 1995;34:2311. [Google Scholar]; (g) Wenger M, Bernstein J. Angew. Chem. Int. Ed. 2006;45:7966. doi: 10.1002/anie.200603241. [DOI] [PubMed] [Google Scholar]; (h) Childs SL, Hardcastle KI. CrystEngComm. 2007;9:364. [Google Scholar]; (i) Bosch E. CrystEngComm. 2007;9:191. [Google Scholar]
  • 2.(a) Metrangolo P, Neukirch H, Pilati T, Resnati G. Acc. Chem. Res. 2005;38:386. doi: 10.1021/ar0400995. [DOI] [PubMed] [Google Scholar]; (b) Metrangolo P, Pilati T, Resnati G, Stevenazzi A. Chem. Commun. 2004:1492. doi: 10.1039/b402305f. [DOI] [PubMed] [Google Scholar]; (c) De Santis A, Forni A, Liantonio R, Metrangolo P, Pilati T, Resnati G. Chem. Eur. J. 2003;9:3974. doi: 10.1002/chem.200204655. [DOI] [PubMed] [Google Scholar]; (d) Walsh RB, Padgett CW, Metrangolo P, Resnati G, Hanks TW, Pennington WT. Cryst. Growth Des. 2001;1:165. [Google Scholar]; (e) Cincic D, Friscic T, Jones W. J. Am. Chem. Soc. 2008;130:7524. doi: 10.1021/ja801164v. [DOI] [PubMed] [Google Scholar]; (f) Cincic D, Friscic T, Jones W. Chemistry–A Eur. J. 2008;14:747. doi: 10.1002/chem.200701184. [DOI] [PubMed] [Google Scholar]; (g) Shirman T, Freeman D, Posner YD, Feldman I, Facchetti A, van der Boom ME. J. Am. Chem. Soc. 2008;130:8162–8163. doi: 10.1021/ja8029784. [DOI] [PubMed] [Google Scholar]; (h) Nguyen HL, Horton PN, Hursthouse MB, Legon AC, Bruce DW. J. Am. Chem. Soc. 2004;126:16–17. doi: 10.1021/ja036994l. [DOI] [PubMed] [Google Scholar]; (i) Triguero S, Llusar R, Polo V, Fourmigué M. Cryst. Growth Des. 2008;8:2241–2247. [Google Scholar]; (j) Meyer EA, Castellano RK, Diederich F. Angew. Chem. Int. Ed. 2003;42:1210. doi: 10.1002/anie.200390319. [DOI] [PubMed] [Google Scholar]
  • 3.(a) Barooah N, Sarma RJ, Baruah JB. CrystEngComm. 2006;8:608. [Google Scholar]; (b) Motohiro N. CrystEngComm. 2004;6:130. [Google Scholar]
  • 4.(a) Grepioni F, Braga D. Making Crystals by Design - from molecules to molecular materials, methods, techniques, applications. Wiley-VCH: 2007. [Google Scholar]; (b) Steed JW, Atwood JL. Supramolecular Chemistry. Chichester: John Wiley & Sons: Ltd; 2000. [Google Scholar]; (c) Desiraju GR. The Crystal as a Supramolecular Entity. New York: John Wiley & Sons: Ltd; 1996. [Google Scholar]; (d) Lehn J-M. Supramolecular chemistry: concepts and perspectives. Weinheim: VCH; 1995. [Google Scholar]
  • 5.Aakeröy CB, Beatty AM, Helfrich BA. Angew. Chem. Int Ed. 2001;40:3240. doi: 10.1002/1521-3773(20010903)40:17<3240::AID-ANIE3240>3.0.CO;2-X. [DOI] [PubMed] [Google Scholar]
  • 6.(a) Mei X, Wolf C. Eur. J. Org. Chem. 2004:4340. [Google Scholar]; (b) Dale SH, Elsegood MRJ, Hemmings M, Wilkinson AL. CrystEngComm. 2004;6:207. [Google Scholar]; (c) Bhogala BR, Nangia A. Cryst. Growth Desn. 2003;3:547. [Google Scholar]; (d) Bensemann I, Gdaniec M, Lakomecka K, Milewska MJ, Polonski T. Org. Biomol. Chem. 2003;1:1425. doi: 10.1039/b211675h. [DOI] [PubMed] [Google Scholar]; (e) Hguyen TL, Fowler FW, Lauher JW. J. Am. Chem. Soc. 2001;123:11057. doi: 10.1021/ja016635v. [DOI] [PubMed] [Google Scholar]
  • 7.Aakeröy CB, Salmon DJ, Smith MM, Desper J. Cryst. Growth Des. 2006;4:1033. [Google Scholar]
  • 8.(a) Vishweshwar P, McMahon JA, Peterson ML, Hickey MB, Shattock TR, Zaworotko MJ. Chem. Commun. 2005;36:4601. doi: 10.1039/b501304f. [DOI] [PubMed] [Google Scholar]; (b) Aakeröy CB, Desper J, Helfrich BA. CrystEngComm. 2004;6:19. [Google Scholar]; (c) Reddy LS, Nangia A, Lynch VM. Cryst. Growth Desn. 2004;4:89. [Google Scholar]; (d) Aakeröy CB, Beatty AM, Helfrich BA, Nieuwenhuyzen M. Cryst. Growth Des. 2003;3:159. [Google Scholar]; (e) Ito Y, Hosomi H, Ohba S. Tetrahedron. 2000;56:6833. [Google Scholar]
  • 9.(a) Saha BK, Nangia A, Jaskólski M. CrystEngComm. 2005;7:355. [Google Scholar]; (b) George S, Nangia A, Lam C-K, Mak TCW, Nicoud J-F. Chem. Commun. 2004:1202. doi: 10.1039/b402050b. [DOI] [PubMed] [Google Scholar]; Reddy LS, Chandran SK, George S, Babu NJ, Nangia A. Cryst. Growth. Des. 2007;12:2675. [Google Scholar]
  • 10.(a) Aakeröy CB, Schultheiss N, Desper J, Moore C. New J. Chem. 2006;30:1452. [Google Scholar]; (b) Thanigaimani K, Muthiah PT, Lynch DE. Acta Cryst. 2006;E62:2976. [Google Scholar]; (c) Balasubramani K, Muthiah PT, Lynch DE. Acta Cryst. 2006;E62:2907. [Google Scholar]; (d) Smith G, Gentner JM, Lynch DE, Byriel KA, Kennard CHL. Aust. J. Chem. 1995;48:1151. [Google Scholar]; (e) Etter MC, Adsmond DA. Chem. Commun. 1990:589. [Google Scholar]
  • 11.(a) Aakeröy CB, Fasulo M, Schultheiss N, Desper J, Moore C. J. Am. Chem. Soc. 2007;129:13772. doi: 10.1021/ja073201c. [DOI] [PubMed] [Google Scholar]; Aakeröy CB, Desper J, Helfrich BA, Metrangolo P, Pilati T, Resnati G, Stevenazzi A. Chem. Commun. 2007:4236. doi: 10.1039/b707458a. [DOI] [PubMed] [Google Scholar]; Bouchmella K, Boury B, Dutremez SG, van der Lee A. Chem.-Eur. J. 2007;13:6130. doi: 10.1002/chem.200601508. [DOI] [PubMed] [Google Scholar]; Goroff NS, Curtis SM, Webb JA, Fowler FW, Lauher JW. Org. Let. 2005;7:1891. doi: 10.1021/ol050184s. [DOI] [PubMed] [Google Scholar]
  • 12.(a) Dunitz JD, Gavezzotti A. Angew Chem. Int. Ed. 2005;44:1766. doi: 10.1002/anie.200460157. [DOI] [PubMed] [Google Scholar]; (b) Brandhost K, Grunenberg J. ChemPhysChem. 2007;8:1151. doi: 10.1002/cphc.200700038. [DOI] [PubMed] [Google Scholar]; (c) Putz MV, editor. Advances in Quantum Chemical Bonding. 2008 [Google Scholar]
  • 13.(a) Aakeröy CB, Desper J, Smith MM. Chem. Commun. 2007;38:3936. doi: 10.1039/b707518a. [DOI] [PubMed] [Google Scholar]; (b) Aakeröy CB, Desper J, Scott BMT. Chem. Commun. 2006;13:1445. doi: 10.1039/b517118k. [DOI] [PubMed] [Google Scholar]; (c) Aakeröy CB, Desper J, Urbina JF. Chem. Commun. 2005;22:2820. doi: 10.1039/b503718b. [DOI] [PubMed] [Google Scholar]
  • 14.Metrangolo P, Resnati G, editors. Structure and Bonding Vol. 126. Halogen bonding: fundamentals and applications. Berlin: Springer; 2008. [Google Scholar]
  • 15.Allen FH. Acta Cryst. 2002;B58:380–388. [Google Scholar]
  • 16.Lynch DE, McClenaghan I. Acta Cryst. 2001;C57:830. doi: 10.1107/s0108270101005819. [DOI] [PubMed] [Google Scholar]
  • 17.Aakeröy CB, Schultheiss N, Desper J. Inorg. Chem. 2005;44:4983. doi: 10.1021/ic048405y. [DOI] [PubMed] [Google Scholar]
  • 18.Aakeröy CB, Schultheiss N, Desper J, Moore C. Cryst. Growth Des. 2007;7:2324. doi: 10.1021/cg8006712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.(a) Leroy J, Schollhorn B, Syssa-Magale J-L, Boubekeur K, Palvadeau P. J. Fluorine Chem. 2004;125:1379. [Google Scholar]; (b) Krebs FC, Jensen T. J. Fluorine Chem. 2003;120:77. [Google Scholar]; (c) Robson MJ, Williams J. #EP 0 196 156 B1. European Patent. 1986
  • 20.SMART v5.060. © 1997 – 1999, Bruker Analytical X-ray Systems. Madison, WI: [Google Scholar]
  • 21.SAINT v6.02. © 1997 – 1999, Bruker Analytical X-ray Systems. Madison, WI: [Google Scholar]
  • 22.SHELXTL v5.10. © 1997, Bruker Analytical X-ray Systems. Madison, WI: [Google Scholar]
  • 23.Aakeröy CB, Fasulo ME, Desper J. Molecular Pharm. 2007;4:317. doi: 10.1021/mp060126o. [DOI] [PubMed] [Google Scholar]
  • 24.Bondi A. J. Phys. Chem. 1964;68:441. [Google Scholar]
  • 25.Rosokha SV, Neretin IS, Rosokha TY, Hecht J, Kochi JK. Heteroatom Chem. 2006;17:449. [Google Scholar]
  • 26.(a) Guardigli C, Liantoni R, Mele ML, Metrangolo P, Resnati G, Pilati T. Supramol. Chem. 2003;15:177. [Google Scholar]; (b) Politzer P, Lane p, Concha MC, Ma Y, Murray JS. J. Mol. Model. 2007;13:305. doi: 10.1007/s00894-006-0154-7. [DOI] [PubMed] [Google Scholar]; (c) Lommerse JPM, Stone AJ, Taylor R, Allen FH. J. Am. Chem. Soc. 1996;118:3108. [Google Scholar]
  • 27.ConQuest, version 5.28. Cambridge, U.K: Cambridge Structural Database; . A typical search was based upon defining the inter-molecular contact X⋯N (X = I or Br) using the distance within the sum of the VdW radii + 0.0 Å. Search criterion included only organics, no ions and an R < 0.05.
  • 28.Metrangolo P, Meyer F, Pilati T, Resnati G, Terraneo GA. Anngew. Chem. Int. Ed. 2008;47:6114. doi: 10.1002/anie.200800128. [DOI] [PubMed] [Google Scholar]; Metrangolo P, Resnati G. Science. 2008;321:918. doi: 10.1126/science.1162215. [DOI] [PubMed] [Google Scholar]

RESOURCES